-The Indian Express Report finds govt did not recover dues of Rs 750 cr from distributors. At a time when the opposition BJP plans to intensify protests against power tariff in Delhi, the Comptroller and Auditor General (CAG) of India's report for the 2011-12 fiscal has slammed the Delhi government for not recovering dues to the tune of Rs 750 crore from private distribution companies. The report, tabled on Tuesday in the Delhi...
More »SEARCH RESULT
Total Matching Records found : 2219
Special kids are going to school but gender GAP has widened
-The Hindustan Times More differently-abled children are going to school, but the gender GAP to access education has risen each year since India launched an ambitious programme to get every child with disabilities into a secondary school. A new NCERT study has shown that 11 out of 13 states that shared data on enrolment of differently-abled students have seen more students with disabilities go to school since 2009-10, when the UPA launched...
More »World Bank chief Jim Yong Kim calls for ending extreme poverty by 2030
-Reuters WASHINGTON: World Bank President Jim Yong Kim called for a commitment by the international community on Tuesday to end extreme poverty by 2030 and to improve the lives of the most vulnerable people living in developing countries. To reach that goal, Kim said the world need to reduce the number of people living below the poverty line of $1.25 per day to 3 percent globally by 2030, and raise the per...
More »Calling big pharma’s bluff -Dwijen Rangnekar
-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...
More »Artful claims can’t decide patent law: court-J Venkatesan
-The Hindu The law of patent in India could not be developed on the artful drafting of claims by companies rather than on the intrinsic worth of invention, the Supreme Court has ruled, rejecting Novartis' claim for patent for its cancer drug. A Bench of Justices Aftab Alam and Ranjana Desai said, "We certainly do not wish the law of patent... to develop on the lines where there may be a vast...
More »
